Stock screenerAll disclosures →
EDGAR →
NVCR
Conviction 51HealthcareScan · Mon, Aug 10, 2026Three outside up
NVCR$17.30+5.55%
ResistanceSupportVol 14Insider sell7
Vol MA14 2.13M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price17.30
Change+5.55%
Gap+0.49%
Rel volume0.84×
Avg volume1.8M
Avg $ vol30.94M
SMA 2016.24
SMA 5016.35
SMA 20013.85
Price vs 50+5.81%
Price vs 200+24.87%
MA stackbullish
50/200 cross—
Supertrenddown · 19.04
RSI (14)56
MACD hist0.06
MACD crossbull · 0d
Stoch %K / %D37 / 25
ADX (14)18
+DI / −DI34 / 19
RSI divergence—
MACD divergence—
ATR %+6.27%
ADR %6.19%
52w high19.99
52w low10.03
From 52w high-13.46%
Above 52w low+72.48%
New 52w highNo
SqueezeOff
Bollinger width27.17%
%B0.74
Donchian pos37.31%
Donchian high21.45
Donchian low14.83
AVWAP (52w high)16.62
vs AVWAP high+4.11%
AVWAP (52w low)14.64
vs AVWAP low+18.20%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d0.84×
Avg vol (14d)2.13M
Avg vol (20d)1.8M
Avg $ vol (20d)30.94M
Market cap2.01B
RS 3m (vs SPY)-8.31%
RS 6m (vs SPY)+48.32%
RS line new highNo
Trend template7/8
Technical rank85.8
1 week+12.92%
1 month+6.13%
3 months-3.30%
6 months+70.61%
1 year+50.30%
YTD+31.86%
P/E-14.79
P/B5.96
P/S3.07
P/FCF-26.62
EPS-1.22
Div yield—
ROE-40.29%
ROA-17.13%
Debt/Eq0.58
Current2.89
EV/EBITDA-15.21
Gross margin74.54%
Net margin-20.79%
Rev growth8.28%
EPS growth19.21%
Price target29.50
Target upside70.52%
Analyst ratingBuy
Institutional95.31%
Ent. value2.12B
Revenue183.58M
Net income-15.66M
Gross profit142.48M
Free cash flow-75.68M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out115.82M
Employees1.6K
ListedFri, Oct 2, 2015
Free float105.15M
Float %90.8%
Short interest11.46M
Days to cover7.5d
Short volume40.7%
Squeeze score47 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.13 vs −$0.30
Last surprise+56.7% beat
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank85.8 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside up
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NVCR
No recent disclosed trades by Congress in NVCR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NVCR · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Leonard Frank X Chief Executive Officer · Ordinary Shares · 2026-06-04 | Sell | 34.27K | $615K | 2026-06-04 | 2026-06-05 |
Ocean Allyson J Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 17K | $0 | 2026-06-03 | 2026-06-05 |
Madden Martin J. Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
HILLEMAN JERYL L Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
Scannell Timothy J Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 17K | $0 | 2026-06-03 | 2026-06-05 |
LEUNG GABRIEL Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
VERNON W ANTHONY Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
Stafford Kristin Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
VERNON W ANTHONY Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 17K | $0 | 2026-06-03 | 2026-06-05 |
Scannell Timothy J Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in NVCR · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.